Gregory M Constantine

Title: Gregory M Constantine: Innovator in Trauma Care and Inflammation Modulation

Introduction

Gregory M Constantine is a notable inventor based in Baden, PA (US). He has made significant contributions to the fields of trauma care and inflammation modulation, holding a total of 3 patents. His work focuses on developing innovative solutions that enhance patient outcomes in critical medical situations.

Latest Patents

One of his latest patents is titled "Time window-based platform for the rapid stratification of blunt trauma patients into distinct outcome cohorts." This invention provides methods for segregating blunt trauma patients into different cohorts based on their risk of multiple organ dysfunction syndrome. The methods utilize patient data obtained shortly after injury, which is crucial for delivering timely treatment and improving patient care.

Another significant patent is the "Self-regulating device for modulating inflammation." This bioreactor contains cells capable of producing cytokine inhibitors in response to cytokines. The device is designed to regulate the release of these inhibitors based on the patient's local or systemic environment, as predicted by mechanistic computational simulations. This innovation is particularly beneficial for patients suffering from conditions such as sepsis, traumatic brain injury, or wound healing.

Career Highlights

Gregory M Constantine is affiliated with the University of Pittsburgh, where he continues to advance his research and innovations. His work has garnered attention for its potential to transform trauma care and inflammation management.

Collaborations

He collaborates with esteemed colleagues, including Qi Mi and Yoram Vodovotz, who contribute to his research endeavors and enhance the impact of his inventions.

Conclusion

Gregory M Constantine's innovative work in trauma care and inflammation modulation exemplifies the importance of research and development in improving patient outcomes. His contributions through his patents reflect a commitment to advancing medical technology and enhancing healthcare practices.